BioAdaptives, Inc. (BDPT)
OTCMKTS · Delayed Price · Currency is USD
0.0091
-0.0009 (-9.00%)
Apr 29, 2026, 1:19 PM EST

BioAdaptives Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-1.56-0.9-0.71-0.9-1.05
Upgrade
Depreciation & Amortization
000.030.060.13
Upgrade
Other Amortization
0.030.050.120.240.22
Upgrade
Asset Writedown & Restructuring Costs
-0.02---
Upgrade
Loss (Gain) From Sale of Investments
--000
Upgrade
Stock-Based Compensation
----0.16
Upgrade
Provision & Write-off of Bad Debts
0----
Upgrade
Other Operating Activities
0.890.420.320.180.14
Upgrade
Change in Accounts Receivable
-0----
Upgrade
Change in Inventory
-0.030.06-0.01-00.01
Upgrade
Change in Accounts Payable
0.050.040.040.180.23
Upgrade
Change in Other Net Operating Assets
0.090.06-0.010-0
Upgrade
Operating Cash Flow
-0.52-0.25-0.22-0.23-0.16
Upgrade
Capital Expenditures
-0.02----
Upgrade
Investing Cash Flow
-0.02----
Upgrade
Short-Term Debt Issued
0.260.030.0500
Upgrade
Long-Term Debt Issued
--0.080.20.26
Upgrade
Total Debt Issued
0.260.030.130.20.26
Upgrade
Short-Term Debt Repaid
---0.05-0.03-0.02
Upgrade
Total Debt Repaid
---0.05-0.03-0.02
Upgrade
Net Debt Issued (Repaid)
0.260.030.080.170.24
Upgrade
Issuance of Common Stock
--0.18--
Upgrade
Financing Cash Flow
0.560.330.260.170.24
Upgrade
Net Cash Flow
0.020.080.04-0.060.08
Upgrade
Free Cash Flow
-0.53-0.25-0.22-0.23-0.16
Upgrade
Free Cash Flow Margin
-2921.68%-1969.51%-783.38%-1323.12%-802.24%
Upgrade
Free Cash Flow Per Share
-0.05-0.03-0.04-0.32-0.70
Upgrade
Cash Interest Paid
---00.02
Upgrade
Levered Free Cash Flow
0.13-0.650.210.15-0.15
Upgrade
Unlevered Free Cash Flow
0.14-0.650.190.09-0.2
Upgrade
Change in Working Capital
0.120.160.020.180.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.